Shanghai Nianxing Industrial Co., Ltd
China
Product Name: KCL-286
Price: Check
Purity: 99.93%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

1952276-71-9

1952276-71-9 structure

1952276-71-9 structure

Name: KCL-286
Chemical Name: KCL-286
CAS Number: 1952276-71-9
Molecular Formula: C₁₉H₁₄N₂O₄
Molecular Weight: 334.33
Catalog: Signaling Pathways Metabolic Enzyme/Protease RAR/RXR
Create Date: 2024-08-09 17:45:20
Modify Date: 2025-08-21 22:32:13
Anticancer agent 168 is an orally active retinoic acid receptor (RAR/RXR) beta2 agonist with ameliorating effects on spinal cord injury (SCI)[1].

Name	KCL-286

Description	Anticancer agent 168 is an orally active retinoic acid receptor (RAR/RXR) beta2 agonist with ameliorating effects on spinal cord injury (SCI)[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Metabolic Enzyme/Protease >> RAR/RXR
Target	RAR β2[1]
References	[1]. Goncalves MB, et al. Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants. Br J Clin Pharmacol. 2023 Jul 15..

Molecular Formula	C₁₉H₁₄N₂O₄
Molecular Weight	334.33

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.